Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-10-06
DOI
10.1038/s41467-022-33169-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identifying and alleviating bias due to differential depletion of susceptible people in post-marketing evaluations of COVID-19 vaccines
- (2022) Rebecca Kahn et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants
- (2022) Emma K. Accorsi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study
- (2022) Sue Ann Costa Clemens et al. LANCET
- Omicron thwarts some of the world’s most-used COVID vaccines
- (2022) Elie Dolgin NATURE
- Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil
- (2022) Thiago Cerqueira-Silva et al. NATURE MEDICINE
- Neutralizing antibodies against the SARS-CoV-2 Omicron variant following homologous and heterologous CoronaVac or BNT162b2 vaccination
- (2022) Samuel M. S. Cheng et al. NATURE MEDICINE
- Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination
- (2022) Eddy Pérez-Then et al. NATURE MEDICINE
- Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022
- (2022) Jill M. Ferdinands et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Use of Recently Vaccinated Individuals to Detect Bias in Test-Negative Case–Control Studies of COVID-19 Vaccine Effectiveness
- (2022) Matt D. T. Hitchings et al. EPIDEMIOLOGY
- Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression
- (2022) Daniel R Feikin et al. LANCET
- Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
- (2022) Nick Andrews et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar
- (2022) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study
- (2022) Alejandro Jara et al. Lancet Global Health
- Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study
- (2022) Martina E McMenamin et al. LANCET INFECTIOUS DISEASES
- Change in covid-19 risk over time following vaccination with CoronaVac: test negative case-control study
- (2022) Matt D T Hitchings et al. BMJ-British Medical Journal
- Theoretical framework for retrospective studies of the effectiveness of SARS-CoV-2 vaccines
- (2021) Joseph A. Lewnard et al. EPIDEMIOLOGY
- Force of infection: a determinant of vaccine efficacy?
- (2021) David C. Kaslow npj Vaccines
- Prevention of Coronavirus Disease 2019 (COVID-19) by mRNA-Based Vaccines Within the General Population of California
- (2021) Kristin L Andrejko et al. CLINICAL INFECTIOUS DISEASES
- Covid-19 Vaccine Effectiveness and the Test-Negative Design
- (2021) Natalie E. Dean et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings
- (2021) Mark G. Thompson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study
- (2021) Otavio T Ranzani et al. BMJ-British Medical Journal
- Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients
- (2021) Lu Lu et al. CLINICAL INFECTIOUS DISEASES
- Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials
- (2021) Gang Zeng et al. LANCET INFECTIOUS DISEASES
- Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
- (2021) Hiam Chemaitelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Use of Test-negative Controls to Monitor Vaccine Effectiveness
- (2019) Huiying Chua et al. EPIDEMIOLOGY
- Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness
- (2016) Sheena G. Sullivan et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings
- (2016) Ivo M. Foppa et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search